Clinical Trial Update: International Immune Tolerance Study [NA]

View source ↗

Summary

The International Immune Tolerance Study for Hemophilia A with inhibitors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia with Inhibitors

Snippet

Sponsor: New York Presbyterian Hospital | Conditions: Hemophilia A With Inhibitors | NA | Status: TERMINATED